Proscia, a leading provider of artificial intelligence (AI)-enabled digital pathology software, has released the findings of a new study on the first deep learning system with proven accuracy in real laboratory environments. The study is the largest AI validation study conducted in pathology to date and supports the growing impact of AI in cancer diagnosis. The paper’s results serve as the foundation for enabling faster and more accurate diagnosis to improve treatment decisions and patient outcomes.
New to digital pathology? Learn how whole slide imaging is changing the industry here.